Hiroe Tsutsumi

Development of simultaneous gas chromatography–mass spectrometric and liquid chromatography–electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine

Hiroe Tsutsumi, Munehiro Katagi, Akihiro Miki et al. · Journal of Chromatography B · 2005 · 67 citations

Main Metabolites, Gas Chromatography, Medicine +12

Adsorption and Stability of Suxamethonium and Its Major Hydrolysis Product Succinylmonocholine Using Liquid Chromatography-Electrospray Ionization Mass Spectrometry

Hiroe Tsutsumi, Mayumi Nishikawa, Munehiro Katagi et al. · JOURNAL OF HEALTH SCIENCE · 2003 · 33 citations · Full text

Solvent Extraction, Engineering, Organic Chemistry +17

Metabolism and the Urinary Excretion Profile of the Recently Scheduled Designer Drug N-Benzylpiperazine (BZP) in the Rat

Hiroe Tsutsumi, Munehiro Katagi, Akihiro Miki et al. · Journal of Analytical Toxicology · 2006 · 27 citations · Full text

Gastrointestinal Pharmacology, Pharmacological Study, Toxicology +17

Urinary excretion of selegiline N -oxide, a new indicator for selegiline administration in man

Munehiro Katagi, Michiaki Tatsuno, Hiroe Tsutsumi et al. · Xenobiotica · 2002 · 24 citations

Urinary Excretion, Ma Abuse, Selegiline Administration +19

Isolation, identification and excretion profile of the principal urinary metabolite of the recently banned designer drug 1-(3-trifluoromethylphenyl)piperazine (TFMPP) in rats

Hiroe Tsutsumi, Munehiro Katagi, Akihiro Miki et al. · Xenobiotica · 2005 · 20 citations